IRIS Accounts Production v25.1.3.33 04934939 Board of Directors 1.12.23 30.11.24 30.11.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh049349392023-11-30049349392024-11-30049349392023-12-012024-11-30049349392022-11-30049349392022-12-012023-11-30049349392023-11-3004934939ns15:EnglandWales2023-12-012024-11-3004934939ns14:PoundSterling2023-12-012024-11-3004934939ns10:Director12023-12-012024-11-3004934939ns10:PrivateLimitedCompanyLtd2023-12-012024-11-3004934939ns10:SmallEntities2023-12-012024-11-3004934939ns10:AuditExempt-NoAccountantsReport2023-12-012024-11-3004934939ns10:SmallCompaniesRegimeForDirectorsReport2023-12-012024-11-3004934939ns10:SmallCompaniesRegimeForAccounts2023-12-012024-11-3004934939ns10:FullAccounts2023-12-012024-11-300493493912023-12-012024-11-3004934939ns10:Director22023-12-012024-11-3004934939ns10:Director32023-12-012024-11-3004934939ns10:Director42023-12-012024-11-3004934939ns10:CompanySecretary12023-12-012024-11-3004934939ns10:RegisteredOffice2023-12-012024-11-3004934939ns5:CurrentFinancialInstruments2024-11-3004934939ns5:CurrentFinancialInstruments2023-11-3004934939ns5:ShareCapital2024-11-3004934939ns5:ShareCapital2023-11-3004934939ns5:SharePremium2024-11-3004934939ns5:SharePremium2023-11-3004934939ns5:RetainedEarningsAccumulatedLosses2024-11-3004934939ns5:RetainedEarningsAccumulatedLosses2023-11-3004934939ns5:NetGoodwill2023-12-012024-11-3004934939ns5:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3004934939ns5:LeaseholdImprovements2023-12-012024-11-3004934939ns5:PlantMachinery2023-12-012024-11-3004934939ns5:FurnitureFittings2023-12-012024-11-3004934939ns5:NetGoodwill2024-11-3004934939ns5:LeaseholdImprovements2023-11-3004934939ns5:PlantMachinery2023-11-3004934939ns5:FurnitureFittings2023-11-3004934939ns5:LeaseholdImprovements2024-11-3004934939ns5:PlantMachinery2024-11-3004934939ns5:FurnitureFittings2024-11-3004934939ns5:LeaseholdImprovements2023-11-3004934939ns5:PlantMachinery2023-11-3004934939ns5:FurnitureFittings2023-11-3004934939ns5:CostValuation2023-11-3004934939ns5:WithinOneYearns5:CurrentFinancialInstruments2024-11-3004934939ns5:WithinOneYearns5:CurrentFinancialInstruments2023-11-3004934939ns5:WithinOneYear2024-11-3004934939ns5:WithinOneYear2023-11-3004934939ns5:BetweenOneFiveYears2024-11-3004934939ns5:BetweenOneFiveYears2023-11-3004934939ns5:AllPeriods2024-11-3004934939ns5:AllPeriods2023-11-30
REGISTERED NUMBER: 04934939 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 November 2024

for

PRESTWICH PHARMACY LIMITED

PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Contents of the Financial Statements
for the Year Ended 30 November 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


PRESTWICH PHARMACY LIMITED

Company Information
for the Year Ended 30 November 2024







DIRECTORS: Mr F G McCaul
Mrs H Hughes
Mr H Hughes
Mr M Williams



SECRETARY: Mrs H Hughes



REGISTERED OFFICE: c/o BTMR Limited
Century Buildings
14 St. Mary's Parsonage
Manchester
M3 2DF



REGISTERED NUMBER: 04934939 (England and Wales)



ACCOUNTANTS: BTMR Limited
Century Buildings
14 St Mary's Parsonage
Manchester
M3 2DF



BANKERS: Lloyds TSB Bank Plc
Burnley Branch
Burnley
Lancashire

PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Balance Sheet
30 November 2024

30.11.24 30.11.23
Notes £    £    £   
FIXED ASSETS
Intangible assets 4 1 -
Tangible assets 5 220,906 166,992
Investments 6 162,981 162,981
383,888 329,973

CURRENT ASSETS
Stocks 181,600 170,859
Debtors 7 400,404 484,313
Cash at bank and in hand 203,766 255,281
785,770 910,453
CREDITORS
Amounts falling due within one year 8 441,561 381,890
NET CURRENT ASSETS 344,209 528,563
TOTAL ASSETS LESS CURRENT
LIABILITIES

728,097

858,536

CAPITAL AND RESERVES
Called up share capital 10,005 10,005
Share premium 92,668 92,668
Retained earnings 625,424 755,863
SHAREHOLDERS' FUNDS 728,097 858,536

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27 May 2025 and were signed on its behalf by:





Mr F G McCaul - Director


PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Notes to the Financial Statements
for the Year Ended 30 November 2024


1. STATUTORY INFORMATION

Prestwich Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is accounted for as revenue when, and to the extent that, the company obtains a right to consideration in exchange for its performance of its obligations under the sales contract with the customer. The amount reported as revenue is the fair value of the right to consideration - usually the price specified in the contractual arrangement net of discounts and net of VAT, and after any allowance for credit risk and other uncertainties.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2024, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Improvements to property - 10% on cost
Plant and machinery - 33% on cost
Fixtures and fittings - 33% on cost

Tangible fixed assets are initially recorded at cost.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024


2. ACCOUNTING POLICIES - continued

Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 31 (2023 - 31 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
Additions 1
At 30 November 2024 1
NET BOOK VALUE
At 30 November 2024 1

5. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and
property machinery fittings Totals
£    £    £    £   
COST
At 1 December 2023 528,588 441,072 127,584 1,097,244
Additions - 127,458 87,045 214,503
Disposals - (171,620 ) - (171,620 )
Reclassification/transfer - (36,415 ) 36,415 -
At 30 November 2024 528,588 360,495 251,044 1,140,127
DEPRECIATION
At 1 December 2023 528,588 274,080 127,584 930,252
Charge for year - 119,436 41,153 160,589
Eliminated on disposal - (171,620 ) - (171,620 )
Reclassification/transfer - (12,138 ) 12,138 -
At 30 November 2024 528,588 209,758 180,875 919,221
NET BOOK VALUE
At 30 November 2024 - 150,737 70,169 220,906
At 30 November 2023 - 166,992 - 166,992

PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024


6. FIXED ASSET INVESTMENTS
Shares in
subsidiary
undertaki
ngs
£   
COST
At 1 December 2023
and 30 November 2024 162,981
NET BOOK VALUE
At 30 November 2024 162,981
At 30 November 2023 162,981

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.24 30.11.23
£    £   
Trade debtors 265,646 256,400
Other debtors 134,758 227,913
400,404 484,313

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.24 30.11.23
£    £   
Trade creditors 257,599 287,513
Taxation and social security 1,997 1,850
Other creditors 181,965 92,527
441,561 381,890

9. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
30.11.24 30.11.23
£    £   
Within one year 45,730 46,404
Between one and five years 64,784 114,693
110,514 161,097

10. ULTIMATE CONTROLLING PARTY

There is no controlling party